Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06682143 · ClinicalTrials.gov registry record · NA
The Effects of Virtual Reality Greenspace on Stress Among Adults With Mobility Impairments
A NA study of Mobility Impairments, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06682143: Recruiting NA study of Mobility Impairments, sponsored by University of Alabama at Birmingham.
NCT06682143 is a NA study of Mobility Impairments that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06682143, a NA study of Mobility Impairments, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to examine the effects of virtual reality greenspace exposure on physiological and affective acute stress responses among adults with mobility impairments.
Primary Outcome
The survey consists of 10 questions that assess the frequency of feelings and thoughts related to stress on a 5-point Likert scale (Never = 0, Almost never = 1, Sometimes = 2, Fairly often = 3; Very often = 4). To calculate a total PSS score, responses to the four positively stated items (items 4, 5, 7 and 8) first need to be reversed (i.e. 0 =\> 4; 1 =\> 3; 2 =\> 2; 3 =\> 1; 4 =\> 0). The PSS score is then obtained by summing across all items. Higher scores indicate higher levels of perceived s
Conditions Studied
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Virtual Reality (VR)
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-04-07 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06682143 shows while recruiting
NCT06682143 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Mobility Impairments appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT06682143 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06682143 about?
NCT06682143 is a clinical study titled "The Effects of Virtual Reality Greenspace on Stress Among Adults With Mobility Impairments". The purpose of this project is to examine the effects of virtual reality greenspace exposure on physiological and affective acute stress responses among adults with mobility impairments.
What is the current status of trial NCT06682143?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-04-07. Estimated completion is 2026-06-30.
What conditions does trial NCT06682143 study?
This clinical trial studies the following conditions: Mobility Impairments.
What interventions are being tested in trial NCT06682143?
The interventions under investigation include: Control (BEHAVIORAL), Virtual Reality (VR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06682143?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06682143 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06682143's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI